AMSF vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AMSF's Piotroski F-Score of 3/9 indicates weak financial health, with no Altman Z-Score available to confirm solvency. Despite a defensive Graham Number of $27.28 and an intrinsic value estimate of $17.29, the stock trades at $32.85—significantly above both benchmarks. This suggests overvaluation, especially given deteriorating earnings growth (-19.2% YoY) and a recent streak of missed earnings (0/4 beats in last 4 quarters). The bearish technical trend and negative insider activity further undermine confidence.
JPM shows bullish fundamentals based on deterministic rules. Financial strength is weak (F-Score 2/9). Key strengths include strong valuation and growth metrics. Price trades at a 109.8% premium to fair value estimate ($140.21), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
AMSF vs JPM: Head-to-Head Comparison
This page compares AMERISAFE, Inc. (AMSF) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.